arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BrightSpring Health Services, Inc.

BTSG

$56.55 ▲ +0.70 (+1.24%) at close

4 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bearish

auto_awesome

Analytical Summary

BrightSpring Health Services, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $11.5B

Dividend Yield —

Revenue Growth 28.2% ↗

Op. Margin 2.3% ↗

ROIC 5.1% ↗

FCF / Share $1.95 ↗

Trailing P/E 60.2x

Price / Book 5.8x

FCF Yield 3.5%

Debt / Equity 1.34

info Valuation on last close. End-of-day price, Sep 22, 2026.

4-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$12.91B

↑ +28.2% —

Net Income Profit after all expenses

$190.67M

↑ +1155.6% —

Operating Margin Operating profit as % of sales

2.3%

↑ +113.4% 34th

FCF / Share Free cash flow per share

$1.95

↑ +758.1% —

Long-Term Debt Long-term obligations

$2.51B

↓ -3.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓

Returns

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	28.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+252%)	14.1% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+76%)	14.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+79%)	—
EPS Growth YoY (%)	N/M	93.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-184.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	N/M	88.3% Excellent Excellent Year-over-year change in net income	-186.8% Weak Weak Year-over-year change in net income	—
Revenue CAGR 3Y (%)	18.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	2.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-85%)	1.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-93%)	1.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-89%)	2.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-84%)
Effective Tax Rate (%) (%)	24.0% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	27.7% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	11.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-18.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	1.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-88%)	-0.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-101%)	-1.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-115%)	-0.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-106%)
FCF Margin (%) (%)	3.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	1.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-1.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	2.07x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	3.16x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.89x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.39x Good Good Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	5.1% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	1.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	3.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	4.6% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	1.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	2.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	10.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-32%)	-1.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-107%)	-26.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	1.34x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+123%)	1.58x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+164%)	5.75x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+859%)	—
Interest Coverage (x)	1.88x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	0.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.45x Weak Weak Operating income divided by interest expense Optimal: > 5x	0.80x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$2.42B	$2.55B	$3.35B	—
Debt / EBITDA (x)	6.83x Weak ↓ Weak Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	14.94x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	14.86x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$63.74	$52.19	$74.88	$65.52
Basic EPS, GAAP (USD)	$0.94	$-0.09	$-1.31	$-0.46
Free Cash Flow per Share (USD)	$1.95	$-0.30	$1.16	$-0.63
Book Value per Share (USD)	$9.76	$9.46	$4.96	—
Tangible Book Value per Share (USD)	$-6.39	$-7.53	$-24.65	—
Basic Weighted Avg Shares (shares)	202.56M	193.00M	117.87M	117.84M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$1.05B	$464.72M	$208.20M	—
LT Debt (USD)	$2.51B	$2.61B	$3.36B	—
Total Equity (USD)	$1.88B	$1.65B	$584.74M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$12.91B	$10.07B	$8.83B	$7.72B
Depreciation Expense (USD)	$71.80M	$66.80M	$79.20M	$77.50M
Net Income, GAAP (USD)	$190.67M	$-18.06M	$-154.60M	$-53.91M
Operating Cash Flow (USD)	$490.17M	$23.77M	$210.78M	$-4.65M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 4 years · 15 quarters

BrightSpring Health Services, Inc.

Analytical Summary

4-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BTSG with peers